Published in Microbiol Immunol on January 01, 1977
Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci U S A (1989) 10.84
Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78
Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect Immun (1988) 6.68
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16
The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease. Infect Immun (1989) 3.75
Serum resistance associated with virulence in Yersinia enterocolitica. Infect Immun (1982) 3.37
Plasmid-mediated and temperature-regulated surface properties of Yersinia enterocolitica. Infect Immun (1983) 3.13
Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. J Bacteriol (1990) 2.84
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun (1989) 2.60
Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect Immun (1995) 2.52
Relationship of HeLa cell infectivity to biochemical, serological, and virulence characteristics of Yersinia enterocolitica. Infect Immun (1982) 2.37
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99
Virulence of Yersinia enterocolitica determined by lethality in Mongolian gerbils and by the Serény test. Infect Immun (1980) 1.97
Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92
Resistance to pesticin, storage of iron, and invasion of HeLa cells by Yersiniae. Infect Immun (1987) 1.80
Production of heat-stable, methanol-soluble enterotoxin by Yersinia enterocolitica. Infect Immun (1979) 1.73
Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72
Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model. Infect Immun (1998) 1.67
The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing. Infect Immun (1993) 1.65
Construction and characterization of a Yersinia enterocolitica O:8 high-temperature requirement (htrA) isogenic mutant. Infect Immun (1996) 1.64
Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59
Nonpathogenic isolates of Yersinia enterocolitica do not contain functional inv-homologous sequences. Infect Immun (1990) 1.56
Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc Natl Acad Sci U S A (2006) 1.36
Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica. J Bacteriol (1998) 1.35
Identification of virulence-associated characteristics in clinical isolates of Yersinia enterocolitica lacking classical virulence markers. Infect Immun (1998) 1.20
Vibrio parahaemolyticus type VI secretion system 1 is activated in marine conditions to target bacteria, and is differentially regulated from system 2. PLoS One (2013) 1.18
Serotype-related HEp-2 cell interaction of Yersinia enterocolitica. Infect Immun (1986) 1.13
Evaluation of iron dextran and mucin for enhancement of the virulence of Yersinia enterocolitica serotype O:3 in mice. Infect Immun (1981) 1.12
In vitro and in vivo characterization of an ail mutant of Yersinia enterocolitica. Infect Immun (1995) 1.08
YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect Immun (1994) 0.98
Yersinia enterocolitica: Mode of Transmission, Molecular Insights of Virulence, and Pathogenesis of Infection. J Pathog (2011) 0.94
Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect Immun (1996) 0.93
Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route. PLoS One (2014) 0.80
Incorporation of [14C]methionine by Yersinia enterocolitica after invasion of HeLa cells. Infect Immun (1981) 0.79
Virulence prediction of Yersinia enterocolitica by pyrolysis gas-liquid chromatography. Appl Environ Microbiol (1980) 0.75
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16
Studies on the pathogenicity of Yersinia enterocolitica. II. Interaction with cultured cells in vitro. Microbiol Immunol (1977) 2.96
Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol (1984) 2.32
Isoforms of caveolin-1 and caveolar structure. J Cell Sci (2000) 1.65
Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolitica and Y. pseudotuberculosis. Microbiol Immunol (1977) 1.64
Correlation between epithelial cell infectivity in vitro and O-antigen groups of Yersinia enterocolitica. Microbiol Immunol (1977) 1.64
Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Antimicrob Agents Chemother (1989) 1.39
Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother (1989) 1.34
In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J Antimicrob Chemother (1990) 1.32
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Infect Immun (1982) 1.22
Observations on the correlation between pathogenicity and serovars of Yersinia enterocolitica by the assay applying cell culture system and experimental mouse infection. Contrib Microbiol Immunol (1979) 1.17
Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib Microbiol Immunol (1991) 1.11
Effect of calcium on the cell infectivity of virulent Shigella flexneri 2a. Jpn J Microbiol (1974) 1.11
Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin. Arzneimittelforschung (1977) 1.11
Divalent cation stimulation of the cell infectivity of Shigella flexneri 2a. Jpn J Microbiol (1975) 1.10
Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases. Antimicrob Agents Chemother (1991) 1.07
Stimulation of non-specific host resistance against Sendai virus and Escherichia coli infections by chitin derivatives in mice. Vaccine (1987) 1.05
Application of cell culture in studying antibacterial activity of rifampicin to Shigella and enteropathogenic Escherichia coli. Jpn J Microbiol (1972) 0.99
Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine. Infect Immun (1983) 0.97
Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog. Infect Immun (1982) 0.96
Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice. Chemotherapy (1986) 0.90
Enhancement of non-specific resistance to Pseudomonas pneumonia by a synthetic derivative of muramoyl dipeptide in immunosuppressed guinea pigs. J Gen Microbiol (1982) 0.88
Maternal origin of a unique extra chromosome, der(9)(pter-->q13::q13-->q12:) in a girl with typical trisomy 9p syndrome. Am J Med Genet (2001) 0.86
Stimulation of non-specific resistance to infection by muroctasin. Arzneimittelforschung (1988) 0.85
Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties. J Pharmacol Exp Ther (1993) 0.85
In vitro activity of DQ-2556, a new cephalosporin. Antimicrob Agents Chemother (1986) 0.84
Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog. Infect Immun (1982) 0.84
Protective role of complement in the development of experimental pneumococcal pneumonia in mice. Chemotherapy (1990) 0.83
In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (1985) 0.83
Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice. Arzneimittelforschung (1988) 0.82
Inhibition of cell to cell transfer of Shigella by treatment with some antibiotics. Jpn J Microbiol (1973) 0.82
Chemotherapeutic evaluation of rifampicin to experimental bacillary dysentery in cynomolgus monkeys. Jpn J Microbiol (1972) 0.81
Virulence of rifampicin-resistant mutants of Shigella and enteropathogenic Escherichia coli with special reference to their cell invasiveness. Jpn J Microbiol (1973) 0.81
Nonbacteremic pseudomonas pneumonia in immunosuppressed guinea pigs. Microbiol Immunol (1982) 0.79
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice. Neuroreport (2003) 0.78
Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs. Arzneimittelforschung (1989) 0.78
Restoration by MDP-Lys (L18) of resistance to Pseudomonas pneumonia in immunosuppressed guinea pigs. Microbiol Immunol (1984) 0.78
Influences of cephem antibiotics on the immune response in mice. Chemotherapy (1990) 0.77
Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro. J Cardiovasc Pharmacol (1993) 0.77
Inhibitory effects of quinolones on murine hematopoietic progenitor cells and eukaryotic topoisomerase II. Chemotherapy (1991) 0.77
Stimulation of macrophages by muroctasin to produce colony-stimulating factors. Arzneimittelforschung (1990) 0.77
Investigations on the pathogenicity of Yersinia enterocolitica by experimental infections in rabbits and cultured cells. Contrib Microbiol Immunol (1979) 0.76
Interaction of Yersinia pestis with mouse peritoneal macrophages in vitro. Contrib Microbiol Immunol (1991) 0.75
Purification and some properties of a hemolysin from the poisonous mushroom Rhodophyllus rhodopolius. Toxicon (1990) 0.75
Antichlamydial activity of ofloxacin. Microbiol Immunol (1986) 0.75
Cefoxitin: synergism with aminoglycosides in vitro. Arzneimittelforschung (1981) 0.75
Chemotherapeutic effect of cefoxitin on experimental pyelonephritis in rats. Comparative study with cefazilin. Arzneimittelforschung (1978) 0.75
Cefoxitin, a semi-synthetic cephamycin antibiotic. Metabolism in rats with renal insufficiency. Arzneimittelforschung (1978) 0.75
Experimental pyelonephritis in mice following ascending infection with C. coli. Acute phase. Acta Pathol Jpn (1981) 0.75
Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin. Arzneimittelforschung (1989) 0.75
[Studies on the toxic components of Rhodophyllus rhodopolius. II. Partial purification and properties of the hemolysin from Rhodophyllus rhodopolius: examination on the condition of the hemolysis]. Yakugaku Zasshi (1988) 0.75
Phase I study and clinical pharmacological study of muroctasin. Arzneimittelforschung (1988) 0.75
In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea. J Antimicrob Chemother (1989) 0.75
[Studies on the toxic components of Rhodophyllus rhodopolius. I. The biological activities and screening of the toxic principles]. Yakugaku Zasshi (1987) 0.75
Muroctasin, a muramyl dipeptide derivative. An introductory overview. Arzneimittelforschung (1988) 0.75
Determination of ofloxacin in bronchoalveolar lavage fluid by high-performance liquid chromatography and fluorimetric detection. J Chromatogr (1989) 0.75
Experimental pyelonephritis in mice following ascending infection with E. coli. Chronic phase. Acta Pathol Jpn (1981) 0.75
Ascending pyelonephritis with Pseudomonas aeruginosa in mice. Acta Pathol Jpn (1982) 0.75